Skip to content
Unrated Drug recall · FDA · Published May 11, 2018

Perrigo Scopolamine Transdermal System Recall: Defective Delivery System

Perrigo recalls specific Scopolamine Transdermal Therapeutic Systems (1 mg/3 days) due to defective delivery system. Affected products include 4-count and 10-count units with certain lot numbers. No remedy is stated in the recall notice.

🇺🇸 FDA recall #D-0816-2018DrugPerrigo ›
Take action

Contact the company

Recalling firmL. Perrigo Company515 Eastern Ave · Allegan, MI 49010-9070
✎ GovInfoNow plain-language explainer

Perrigo is recalling specific batches of Scopolamine Transdermal Therapeutic Systems (1 mg/3 days) because of a defective delivery system. This could lead to improper medication delivery, but the recall does not specify a remedy. Read more at govinfonow.com/recall/40554-perrigo-scopolamine-transdermal-system-recall-defective-delivery-system.

Source Summary by GovInfoNow · govinfonow.com/recall/40554-perrigo-scopolamine-transdermal-system-recall-defective-delivery-system · Updated October 7, 2026 · FDA enforcement record: FDA #D-0816-2018

Cite this page

“Perrigo Scopolamine Transdermal System Recall: Defective Delivery System.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40554-perrigo-scopolamine-transdermal-system-recall-defective-delivery-system. Based on FDA recall #D-0816-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0816-2018%22&limit=1).

The FDA announced on May 11, 2018, that L. Perrigo Company is recalling Scopolamine Transdermal Therapeutic Systems due to a defective delivery system. The recall affects 569,520 cartons distributed nationwide.

How to tell if you have it

  • Brand: Perrigo
  • Product: Scopolamine Transdermal Therapeutic System, 1 mg/3 days
  • NDC 45802-580-84 (4-count)
  • NDC 45802-580-46 (10-count)
  • NDC 45802-580-62 (24-count)
  • Lot codes: 46397, 46457, 46621, 46894, 46904, 46905, 47133, 47153, 47154, 47213, 47214, 46695, 46994, 47012, 47322, 46822, 47155, 47212
  • Expiration dates: 03/19, 04/19, 05/19, 06/19, 07/19, 08/19, 09/19, 10/19

The hazard

The product has a defective delivery system. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show L. Perrigo Company has 7 other recalls on record since December 28, 2016. Other recent recalls of similar products include Bell Pharmaceuticals Clinere Carbamide Peroxide Recall (June 25, 2026), Golden State Medical Recalls Prasugrel HCl 10mg Tablets (August 21, 2026), and Teva Clonidine Transdermal System Recall (March 19, 2026).

How to tell if you have this one

Check the product label for the quantity (4-count or 10-count) and the lot number listed in the recall notice. The product is prescription-only and distributed by Perrigo.

  • Brand
    Perrigo
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the product quantity (4-count or 10-count) and lot number to determine if it is recalled.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the U.S.A.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.4 years after the firm started it.

1. Firm started the recall: May 11, 201812. FDA classified it Class II: May 15, 201823. Published in FDA’s Enforcement Report: May 23, 201834. FDA terminated the recall: Sep 28, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0816-2018 (May 11, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0816-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA